Common questions about Ketorolac (FAQ)
Q: Why is Ketorolac sometimes given as an injection instead of a pill?
A: Regulatory documents describe that the medicine is available in various forms, including an injection, to allow administration when a patient cannot take medicine by mouth. The injectable form is utilized for its ability to provide rapid delivery for acute pain, as described in official sources.
Q: How quickly does Ketorolac usually start to relieve pain?
A: Official information indicates that the onset of pain relief can vary. For the oral tablet, the peak pain-relieving effect is described as typically occurring within 2 to 3 hours. For the injectable form, the time to onset of pain relief varies, with effects observed in clinical studies for some patients within 20 minutes.
Q: How long does the effect of one dose of Ketorolac last?
A: The elimination half-life of the medication, which describes the time it takes for half the drug to be eliminated from the body, is typically between 5 and 7 hours in healthy younger adults. The duration of observable pain relief from a single dose can vary between individuals.
Q: Is Ketorolac considered a narcotic or opioid pain reliever?
A: No, Ketorolac is officially classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). Official sources note that it is a non-narcotic analgesic and is not classified as an opioid or controlled substance.
Q: Do you feel drowsy or sleepy after taking Ketorolac?
A: Official drug labels list both dizziness and drowsiness as common side effects that may occur in patients using the medication.
Q: Does taking Ketorolac affect driving or operating machinery?
A: Since official documents list dizziness and drowsiness as possible effects, caution is recommended regarding activities that require full alertness. This includes driving or operating machinery while taking the medication.
Q: Why is Ketorolac often used in hospital or post-surgery settings?
A: Regulatory documents indicate the medication is used for the short-term management of moderately severe acute pain. The injectable solution is noted for its utility in providing pain relief, and its use is often initiated in controlled settings such as hospitals after a surgical procedure.
Q: Is there any difference between the oral (pill) and injectable forms of Ketorolac?
A: Yes, there are differences in how they are used. The injectable form is typically used first to initiate pain relief, while the oral tablet is generally intended only as continuation therapy following the initial injection. The injectable form is also described as reaching its peak effect more rapidly than the oral tablet.
Q: Does Ketorolac help with swelling as well as pain?
A: Yes. The medicine is officially classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). Its NSAID classification indicates that it possesses both pain-relieving (analgesic) and anti-inflammatory activity, as described in official documents.
Q: Why are people with a history of ulcers often advised against using Ketorolac?
A: The medicine is strictly contraindicated in patients who have a history of peptic ulcer disease or gastrointestinal bleeding. This prohibition is due to the drug’s documented potential to cause serious gastrointestinal events, which increases the risk in patients with prior ulcer history.
Q: Can people with heart conditions use Ketorolac?
A: Official labeling contains a Boxed Warning that all NSAIDs, including Ketorolac, may increase the risk of serious cardiovascular events such as heart attack and stroke. The medicine is noted to be contraindicated for pain relief after coronary artery bypass graft (CABG) surgery.
Q: Are there certain age groups who should avoid Ketorolac?
A: Yes, regulatory documents note restrictions for specific age groups. The medicine is not indicated for use in pediatric patients because safety and effectiveness have not been established. Use in older adults (65 years and older) is permitted but requires a lower total maximum daily dose due to a heightened risk of adverse effects.
Q: What happens if I forget to take a dose of Ketorolac?
A: Official administration documents state that if a dose is missed, it should be taken as soon as it is remembered. Official guidance states that a double dose should not be taken to make up for the forgotten dose.
Q: Is it normal to feel a burning sensation after receiving a Ketorolac injection?
A: Official data and post-marketing reports list pain, discomfort, or a burning sensation at the injection site as a common or reported side effect that may occur after administration of the intramuscular injection.
Q: What is the risk of having an allergic reaction to Ketorolac?
A: The medicine is strictly contraindicated for patients who have previously demonstrated a hypersensitivity (allergic reaction) to Ketorolac, aspirin, or other NSAIDs. Serious hypersensitivity reactions, including anaphylaxis, have been reported in the official safety information.
Q: What does the official information say about Ketorolac and pregnancy?
A: Official information states the drug is contraindicated from 30 weeks of gestation onward due to documented risks to the developing fetus. Use between 20 and 30 weeks of gestation requires careful consideration and is limited to the lowest effective dose for the shortest possible duration.
Q: What information is available about Ketorolac and breastfeeding?
A: Official labeling states that Ketorolac is excreted into human milk. Therefore, official guidance notes that a decision must be made whether to stop nursing or discontinue the drug, considering the importance of the medicine to the mother.
Q: Is it necessary to stop taking Ketorolac before surgery?
A: Official regulatory documents indicate that the medicine is contraindicated for routine use as a pain reliever before major surgery due to its effect on platelet function, which is linked to an increased risk of bleeding.
Q: Does Ketorolac interact with any common anti-depressant medications?
A: Official documents describe a known interaction with Selective Serotonin Reuptake Inhibitors (SSRIs), which are a type of antidepressant. Co-administration of these medicines is linked to an additive risk of gastrointestinal bleeding.
Q: How does Ketorolac compare in strength to other NSAIDs?
A: Ketorolac is consistently described in official regulatory documents as a potent non-narcotic analgesic. Clinical studies have examined its pain-relieving effects in various settings.
Q: Can Ketorolac be used to reduce fever?
A: While the mechanism of action involves the body’s temperature regulation, official documentation states that Ketorolac is indicated only for the short-term management of moderately severe acute pain. Fever reduction (antipyresis) is not listed as an approved use for the medication.
Q: Do different brands of Ketorolac work exactly the same way?
A: Yes, different brands of the systemic formulations contain the same active ingredient, Ketorolac tromethamine. In the United States, generic versions are approved only after demonstrating bioequivalence—meaning they work the same way in the body—to the original branded product.
Q: Is Ketorolac available without a prescription in some places?
A: The systemic formulations of Ketorolac, including the tablet, injection, and nasal spray, are classified as prescription-only medicines by regulatory authorities and are not available over-the-counter.
Q: What are the documented long-term effects of Ketorolac use?
A: Regulatory documents state that the total duration of systemic therapy is limited to five days. This is due to the officially documented risk of serious side effects, including gastrointestinal bleeding and cardiovascular thrombotic events, which increase with both the dose and the duration of use.
